Skip to main content
Log in

Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goal of the work

The quality of life (QoL) of patients with cancer is a major area of concern for both patients and their physicians. The independent contribution of functional impairment and co-morbidity to QoL is unclear.

Materials and methods

We investigated initial global QoL in 477 patients: 195 cancer patients aged 60 years or older (group A), 152 cancer patients below the age of 60 years (group B), admitted as inpatients for chemotherapy initiation and 130 patients aged 60 years or older admitted for non-cancer-related disorders (group C). Global QoL was assessed by the EORTC-QLQ-C30 subscale, functional status by the Karnofsky Performance Scale (KPS) and the Instrumental Activities of Daily Living (IADL) scale, and co-morbidity by the Cumulative Illness Rating Scale (CIRS).

Results

In multivariate analyses, global QoL is significantly associated with KPS, IADL and co-morbidity in group A (r 2 = 0.27), with KPS and IADL in group B (r 2 = 0.23), and with age, KPS and IADL in group C (r 2 = 0.38).

Conclusions

IADL contributes to global QoL in addition to the known effect of KPS. In addition, co-morbidity independently influences global QoL in elderly cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108

    PubMed  Google Scholar 

  2. Edwards BK, Howe HL, Ries LA et al (2002) Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94(10):2766–2792

    Article  PubMed  Google Scholar 

  3. Karnofsky DA, Adelmann WH, Craver FL (1948) The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1:634–656

    Article  Google Scholar 

  4. Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A(7):1135–1141

    Article  PubMed  CAS  Google Scholar 

  5. Mor V, Laliberte L, Morris JN et al (1984) The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer 53(9):2002–2007

    Article  PubMed  CAS  Google Scholar 

  6. Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45(8):2220–2224

    Article  PubMed  CAS  Google Scholar 

  7. Conill C, Verger E, Salamero M (1990) Performance status assessment in cancer patients. Cancer 65(8):1864–1866

    Article  PubMed  CAS  Google Scholar 

  8. Mahoney FI, Barthel DW (1965) Functional evaluation. Md Med J 14:61–65

    CAS  Google Scholar 

  9. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186

    PubMed  CAS  Google Scholar 

  10. Extermann M, Overcash J, Lyman GH et al (1998) Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16(4):1582–1587

    PubMed  CAS  Google Scholar 

  11. Schaafsma J, Osoba D (1994) The Karnofsky performance status scale re–examined: a cross–validation with the EORTC–C30. Qual Life Res 3(6):413–424

    Article  PubMed  CAS  Google Scholar 

  12. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  PubMed  CAS  Google Scholar 

  13. Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36(4):453–471

    Article  PubMed  CAS  Google Scholar 

  14. Kempen GI, Ormel J, Brilman EI et al (1997) Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health 87(1):38–44

    Article  PubMed  CAS  Google Scholar 

  15. Michelson H, Bolund C, Brandberg Y (2000) Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res 9(10):1093–104

    Article  PubMed  CAS  Google Scholar 

  16. Trentham-Dietz A, Remington PL, Moinpour CM et al (2003) Health-related quality of life in female long-term colorectal cancer survivors. Oncologist 8(4):342–349

    Article  PubMed  CAS  Google Scholar 

  17. Vacek PM, Winstead-Fry P, Secker-Walker RH et al (2003) Factors influencing quality of life in breast cancer survivors. Qual Life Res 12(5):527–537

    Article  PubMed  Google Scholar 

  18. Sarna L, Padilla G, Holmes C et al (2002) Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 20(13):2920–2929

    Article  PubMed  Google Scholar 

  19. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of cancer QLQ–C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376

    Article  PubMed  CAS  Google Scholar 

  20. Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16(5):622–626

    PubMed  CAS  Google Scholar 

  21. Pinquart M, Duberstein PR (2004) Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol 51(1):69–80

    Article  PubMed  Google Scholar 

  22. Hjermstad MJ, Fayers PM, Bjordal K et al (1998) Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ = C30 (+3). J Clin Oncol 16(3):1188–1196

    PubMed  CAS  Google Scholar 

  23. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351

    Article  PubMed  CAS  Google Scholar 

  24. Michelson H, Bolund C, Nilsson B et al (2000) Health–related quality of life measured by the EORTC QLQ-C30—reference values from a large sample of Swedish population. Acta Oncol 39(4):477–484

    Article  PubMed  CAS  Google Scholar 

  25. Thome B, Dykes AK, Hallberg IR (2004) Quality of life in old people with and without cancer. Qual Life Res 13(6):1067–1080

    Article  PubMed  Google Scholar 

  26. Schag CA, Ganz PA, Wing DS et al (1994) Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 3(2):127–141

    Article  PubMed  CAS  Google Scholar 

  27. Chang VT, Hwang SS, Feuerman M et al (2000) Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88(5):1175–1183

    Article  PubMed  CAS  Google Scholar 

  28. Hollen PJ, Gralla RJ, Kris MG et al (1994) Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale. Cancer 73(8):2087–2098

    Article  PubMed  CAS  Google Scholar 

  29. Llobera J, Esteva M, Benito E et al (2003) Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index. Support Care Cancer 11(5):294–303

    PubMed  Google Scholar 

  30. Hollen PJ, Gralla RJ, Kris MG et al (1999) Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 7(3):140–148

    Article  PubMed  CAS  Google Scholar 

  31. Thome B, Hallberg IR (2004) Quality of life in older people with cancer—a gender perspective. Eur J Cancer Care (Engl) 13(5):454–463

    Article  CAS  Google Scholar 

  32. Elliott BA, Renier CM, Haller IV et al (2004) Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses. Qual Life Res 13(2):457–462

    Article  PubMed  Google Scholar 

  33. Greimel ER, Padilla GV, Grant MM (1997) Physical and psychosocial outcomes in cancer patients: a comparison of different age groups. Br J Cancer 76(2):251–255

    PubMed  CAS  Google Scholar 

  34. Friedrich C, Kolb G, Wedding U et al (2003) Comprehensive geriatric assessment in the elderly cancer patient. Onkologie 26(4):355–360

    Article  PubMed  CAS  Google Scholar 

  35. Extermann M, Aapro M, Bernabei R et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55(3):241–252

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The study was supported by German Cancer Aid (Grant No. 70-2445-Hö-3). Ulrich Wedding is currently a research fellow of the “Forschungskolleg Geriatrie” of the Robert Bosch Foundation, Stuttgart.

Conflict of interest statement

None of the authors has to indicate a potential source of conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich Wedding.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wedding, U., Röhrig, B., Klippstein, A. et al. Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients. Support Care Cancer 15, 1097–1104 (2007). https://doi.org/10.1007/s00520-007-0228-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0228-9

Keywords

Navigation